Lung-Delivered IL-10 Mitigates Lung Inflammation Induced by Repeated Endotoxin Exposures in Male Mice
-
2025/02/01
-
Details
-
Personal Author:Duryee MJ ; Gleason AM ; Mikuls TR ; Mosley DD ; Nelson AJ ; Poole JA ; Schanze OW ; Schwab AD ; Thiele GM ; Wyatt TA
-
Description:Therapies capable of resolving inflammatory lung disease resulting from high-consequence occupational/environmental hazards are lacking. This study seeks to determine the therapeutic potential of direct lung-delivered interleukin (IL)-10 following repeated lipopolysaccharide exposures. C57BL/6 mice were intratracheally instilled with LPS (10 µg) and treated with IL-10 (1 µg) or vehicle control for 3 days. Lung cell infiltrates were enumerated by flow cytometry. Lung sections were stained for myeloperoxidase (MPO), CCR2, vimentin, and post-translational protein citrullination (CIT) and malondialdehyde-acetaldehyde (MAA) modifications. Lung function testing and longitudinal in vivo micro-CT imaging were performed. Whole lungs were profiled using bulk RNA sequencing. IL-10 treatment reduced LPS-induced weight loss, pentraxin-2, and IL-6 serum levels. LPS-induced lung proinflammatory and wound repair mediators (i.e., TNF-a, IL-6, CXCL1, CCL2, MMP-8, MMP-9, TIMP-1, fibronectin) were decreased with IL-10. IL-10 reduced LPS-induced influx of lung neutrophils, CD8+ T cells, NK cells, recruited monocyte-macrophages, monocytes, and tissue expression of CCR2+ monocytes-macrophages, MPO+ neutrophils, vimentin, CIT, and MAA. IL-10 reduced LPS-induced airway hyperresponsiveness and improved lung compliance. Micro-CT imaging confirmed the reduction in LPS-induced lung density by IL-10. Lung-delivered IL-10 therapy administered after daily repeated endotoxin exposures strikingly reduces lung inflammatory and wound repair processes to decrease lung pathologic changes and mitigate airway dysfunction. [Description provided by NIOSH]
-
Subjects:
-
Keywords:
-
ISSN:2051-817X
-
Document Type:
-
Funding:
-
Genre:
-
Place as Subject:
-
CIO:
-
Topic:
-
Location:
-
Volume:13
-
Issue:4
-
NIOSHTIC Number:nn:20070523
-
Citation:Physiol Rep 2025 Feb; 13(4):e70253
-
Contact Point Address:Jill A. Poole, Division of Allergy & Immunology, University of Nebraska Medical Center, Omaha, Nebraska
-
Email:japoole@unmc.edu
-
Federal Fiscal Year:2025
-
Performing Organization:University of Nebraska Medical Center
-
Peer Reviewed:True
-
Start Date:20210901
-
Source Full Name:Physiological Reports
-
End Date:20250831
-
Collection(s):
-
Main Document Checksum:urn:sha-512:a2b21c51b9edbc3db40cfc3f4854b9e014e66316b8f701b79bf8a76efec23a6998175681b78dc8607c3067356624bb52782df1a0b7258fe7c63975c7e340898a
-
Download URL:
-
File Type:
ON THIS PAGE
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings,
journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like